Efficacy of Focused Extracorporeal Shock Wave Therapy After Anterior Cruciate Ligament Rec
The aim of this clinical trial is to determine the effectiveness of fESWT in rehabilitation after ACL reconstruction. The main questions it aims to answer are: Is fESWT applied in addition to conventional physiotherapy effective in physiotherapy-related parameters? Researchers will compare conventional physiotherapy an
| Condition(s) | ACL Reconstruction, Extracorpereal Shock Wave Therapy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The aim of this clinical trial is to determine the effectiveness of fESWT in rehabilitation after ACL reconstruction. The main questions it aims to answer are: Is fESWT applied in addition to conventional physiotherapy effective in physiotherapy-related parameters? Researchers will compare conventional physiotherapy and conventional physiotherapy + fESWT to see if fESWT provides benefits in addition to conventional physiotherapy. Participants: They will receive the conventional physiotherapy program 2 days per week. In addition, the intervention group will receive low-intensity fESWT 1 day per week. Participants' muscle strength, postural balance, range of motion, pain scores and functional status will be assessed. |
| Who can participate | Inclusion Criteria: * Age between 18 and 45 years * Unilateral ACL rupture * Isolated ACL injury * Hamstring graft Exclusion Criteria: * Previous knee injury and anterior cruciate ligament revision * Synovitis, stiffness, tension * History of systemic diseases such as rheumatoid arthritis, osteoarthritis, osteoporosis * Presence of tumor * Deep vein thrombosis or vascular pathology in the lower extremity * RA or accompanying comorbidities * Having had intra-articular injection within 6 months * Cognitive impairment |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Lead sponsor | Berivan Beril Kılıç |
| Locations | Istanbul, Turkey (Türkiye) |
| Start date | 2024-12-01 |
| NCT ID | NCT06688344 |
| Official listing | https://clinicaltrials.gov/study/NCT06688344 |